Literature DB >> 7213523

Theophylline-salbutamol interaction: bronchodilator response to salbutamol at maximally effective plasma theophylline concentrations.

J Barclay, B Whiting, P A Meredith, G J Addis.   

Abstract

1 The effect of inhaled salbutamol following a maximally effective dose of theophylline given by intravenous infusion was determined in 12 patients with chronic bronchitis. 2 An initial single intravenous dose study was performed to estimate each patient's theophylline kinetics and to identify those patients who would respond to theophylline. 3 Pulmonary function was assessed at hourly intervals during four to five incremental steady state theophylline infusions over the concentration range 5-25 mg/l. 4 Inhaled salbutamol (400 micrograms) was administered after the maximum effect from theophylline had been achieved or when theophylline concentrations reached 25 mg/l without maximum effect: pulmonary function was again assessed. 5 Ten patients achieved a further significant improvement in pulmonary function after salbutamol: in five, predicted values for FVC were exceeded. 6 Patients with chronic bronchitis may benefit from the combination of theophylline and salbutamol if steady state theophylline concentrations of 15-20 mg/l are achieved.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7213523      PMCID: PMC1401579          DOI: 10.1111/j.1365-2125.1981.tb01125.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  5 in total

1.  Potentiation of isoprenaline-induced plasma cyclic AMP response by aminophylline in normal and asthmatic subjects.

Authors:  P W Trembath; J Shaw
Journal:  Br J Clin Pharmacol       Date:  1978-12       Impact factor: 4.335

2.  Assessment of combined oral theophylline and inhaled beta-adrenoceptor agonist bronchodilator therapy.

Authors:  G E Marlin; B J Hartnett; N Berend; N B Hacket
Journal:  Br J Clin Pharmacol       Date:  1978-01       Impact factor: 4.335

3.  Bronchodilator effects of terbutaline and aminophylline alone and in combination in asthmatic patients.

Authors:  J D Wolfe; D P Tashkin; B Calvarese; M Simmons
Journal:  N Engl J Med       Date:  1978-02-16       Impact factor: 91.245

4.  A safe method for rapidly achieving plasma concentration plateaus.

Authors:  J G Wagner
Journal:  Clin Pharmacol Ther       Date:  1974-10       Impact factor: 6.875

5.  Inhalation of beta-stimulants: dose-response relationship.

Authors:  U Wildbolz; H Bachofen; M Scherrer
Journal:  Lung       Date:  1978       Impact factor: 2.584

  5 in total
  12 in total

Review 1.  New drugs in respiratory disorders: I.

Authors:  D C Flenley
Journal:  Br Med J (Clin Res Ed)       Date:  1983-03-12

2.  What role for theophylline?

Authors:  J W Jenne
Journal:  Thorax       Date:  1994-02       Impact factor: 9.139

3.  Slow release theophyllines and chronic bronchitis.

Authors:  G M Cochrane
Journal:  Br Med J (Clin Res Ed)       Date:  1984-12-15

4.  Do saliva concentrations predict plasma unbound theophylline concentrations? A problem re-examined.

Authors:  C Knott; M Bateman; F Reynolds
Journal:  Br J Clin Pharmacol       Date:  1984-01       Impact factor: 4.335

5.  Plasma theophylline concentrations, six minute walking distances, and breathlessness in patients with chronic airflow obstruction.

Authors: 
Journal:  Br Med J (Clin Res Ed)       Date:  1985-01-12

6.  How many blows really make an FEV1, FVC, or PEFR?

Authors:  M I Ullah; V Cuddihy; K B Saunders; G J Addis
Journal:  Thorax       Date:  1983-02       Impact factor: 9.139

Review 7.  Fixed combination drug therapy.

Authors:  G M Shenfield
Journal:  Drugs       Date:  1982-06       Impact factor: 9.546

Review 8.  Combination bronchodilator therapy.

Authors:  G M Shenfield
Journal:  Drugs       Date:  1982-11       Impact factor: 9.546

9.  The influence of theophylline on maximal response to salbutamol in severe chronic obstructive pulmonary disease.

Authors:  J Barclay; B Whiting; G J Addis
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

10.  Modelling theophylline response in individual patients with chronic bronchitis.

Authors:  B Whiting; A W Kelman; J Barclay; G J Addis
Journal:  Br J Clin Pharmacol       Date:  1981-10       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.